Transcatheter Mitral Valve Replacement with Intrepid

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Transcatheter mitral valve replacement with the Intrepid device is intended for patients who need mitral valve replacement and who are at an increased risk for conventional surgery. The early published results of the early feasibility trial are reviewed as well as device design and the implant procedure. The Apollo trial is reviewed: a randomized trial of the Intrepid device versus conventional surgery including a single arm study for inoperable patients. The mitral valve structure, pathophysiology, and postimplant physiology pose unique hurdles for any transcatheter implant.

Original languageEnglish (US)
Pages (from-to)287-294
Number of pages8
JournalInterventional Cardiology Clinics
Issue number3
StatePublished - Jul 2019


  • Apollo trial
  • Mitral regurgitation
  • Mitral valve
  • Transcatheter mitral valve replacement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Transcatheter Mitral Valve Replacement with Intrepid'. Together they form a unique fingerprint.

Cite this